T1	Participants 344 465	Two hundred patients with stage III/IV NPC were randomly allocated into the treatment group (N=100) and the control group
T2	Participants 491 504	control group
T3	Participants 576 591	treatment group
T4	Participants 863 878	treatment group
T5	Participants 936 949	control group
T6	Participants 1001 1016	treatment group
T7	Participants 1044 1057	control group
T8	Participants 1154 1169	treatment group
T9	Participants 1267 1282	treatment group
T10	Participants 1325 1338	control group
T11	Participants 1367 1382	treatment group
